August 18th 2025
Hypertensive disorders in pregnancy affect fetal growth differently by sex, with males prioritizing growth and females adapting via placental development.
Recognizing depression in gynecologic patients
June 1st 2004Nearly twice as many women as men suffer from clinical depression, and up to 50% of ob/gyn patients have the disorder or its symptoms. Since you may be the only clinician many of these women see, you're uniquely positioned to detect its presence and steer patients toward appropriate treatment.
Read More
A practical approach to hyperemesis gravidarum
June 1st 2004Delay in aggressively treating out-of-control, unremitting vomiting in pregnancy can dehydrate, deplete, and nearly starve a woman and her fetus. This expert's approach tells you how to quickly distinguish developing hyperemesis gravidarum from something more benign.
Read More
Grand Rounds: Rh disease: It's still a threat
May 1st 2004Once a common cause of perinatal death, Rh disease is now quite rare in pregnant women, thanks in large part to advances in U/S and DNA technology. But the fact that roughly 7 out of every 1,000 liveborn infants are delivered by Rh-sensitized women emphasizes the need for more vigorous preventive efforts and up-to-date management skills.
Read More
Identifying perinatal depression--sooner is better
April 1st 2004Depression does occur in pregnant women and not just in those with preexisting mood symptoms. Knowing how to detect the disorder and when to refer is important because you may be the only physician these patients see during the perinatal period.
Read More
Cover Story: Contraception choices for 2004
February 1st 2004Women need thorough and accurate information about the entire array of contraceptive options--new and old--so they can find their ideal method. Adherence--not efficacy--is the problem, and the hope is that greater choice will translate into fewer unintended pregnancies.
Read More
Cover Story: Preventing breast Ca with aromatase inhibitors
December 1st 2003With new research showing that aromatase inhibitors can dramatically cut the risk of recurring breast cancer, patients will probably have many questions about drugs like anastrozole and letrozole. Two experts review the scientific evidence on these valuable agents.
Read More
Treatment options for vulvar vestibulitis
October 1st 2003Considering how successful surgery is, how do you tell a young woman who's unable to have intercourse that she needs to learn to live with her pain? Even so, a surgical approach is only for carefully selected women--usually those with primary vestibulitis who have exhausted other treatment options.
Read More
Cover Story: Should your patients be on extended-use OCs?
September 1st 2003Women treated with OCs for menstrual disorders like dysmenorrhea and irregular bleeding may not want to put up with the withdrawal symptoms linked with the standard regimen's 7-day hormone-free interval. Extending active therapy and reducing hormone-free days can improve their quality of life.
Read More
Do liquid-based Pap smears need a transformation zone component?
July 1st 2003A many as 20% of specimens from liquid-based cytology may lack a TZ component. The author examines the evidence on whether that should be of concern to clinicians and reveals two easy steps that can help you obtain more TZ in Pap specimens.
Read More